These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 6391515
21. Simplified PET quantitation of myocardial glucose utilization. Nakagawa K, Namba H, Iyo M, Fukushi K, Irie T, Yamanouchi M, Shikama N, Himi T, Yoshida K, Masuda Y. J Nucl Med; 1995 Nov; 36(11):2094-102. PubMed ID: 7472605 [Abstract] [Full Text] [Related]
27. Cardiac positron tomography: current status and future directions. Geltman EM, Roberts R, Sobel BE. Herz; 1980 Apr; 5(2):107-19. PubMed ID: 6970158 [Abstract] [Full Text] [Related]
28. Regional heterogeneity of cardiac substrate metabolism? Schwaiger M, Hicks R. J Nucl Med; 1990 Nov; 31(11):1757-60. PubMed ID: 2230988 [No Abstract] [Full Text] [Related]
29. [Evaluation of myocardial glucose utilization of hypertrophic and dilated cardiomyopathy using 18F-2-fluoro 2-deoxy-D-glucose and positron emission tomography]. Ohtake T, Kosaka N, Watanabe T, Momose T, Nishikawa J, Sasaki Y, Iio M, Yokoyama I, Iizuka M, Sugimoto T. Nihon Rinsho; 1991 Jan; 49(1):143-7. PubMed ID: 2002593 [No Abstract] [Full Text] [Related]
33. Silent myocardial ischemia in patients with myocardial infarction: evaluation with positron emission computed tomography. Kambara H, Fudo T, Hashimoto T, Hayashi M, Kawai C, Tamaki N, Yamashita K, Yonekura Y, Konishi J. Jpn Circ J; 1989 Nov; 53(11):1437-43. PubMed ID: 2621773 [Abstract] [Full Text] [Related]
34. [Myocardial blood flow and glucose metabolism in patients with myocardial infarction evaluated by positron emission tomography: comparison with left ventriculography]. Fudo T, Kambara H, Hashimoto T, Hayashi M, Kawai C, Senda M, Tamaki N, Yonekura Y. J Cardiol; 1988 Mar; 18(1):13-20. PubMed ID: 3265437 [Abstract] [Full Text] [Related]
37. C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. Schelbert HR, Henze E, Schon HR, Keen R, Hansen H, Selin C, Huang SC, Barrio JR, Phelps ME. Am Heart J; 1983 Mar; 105(3):492-504. PubMed ID: 6600872 [No Abstract] [Full Text] [Related]
38. [Positron emission tomography of the brain. A diagnostic technic on the threshold of clinical use]. Heiss WD. Dtsch Med Wochenschr; 1983 Jun 10; 108(23):887-90. PubMed ID: 6602042 [No Abstract] [Full Text] [Related]
39. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. Gambhir SS, Schwaiger M, Huang SC, Krivokapich J, Schelbert HR, Nienaber CA, Phelps ME. J Nucl Med; 1989 Mar 10; 30(3):359-66. PubMed ID: 2786939 [Abstract] [Full Text] [Related]
40. Application of positron emission tomography in the heart. Council on Scientific Affairs. Report of the Positron Emission Tomography Panel. JAMA; 1989 Mar 10; 259(16):2438-45. PubMed ID: 3280846 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]